# Filip Jankú

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/filip-janku/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,226 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 80 |
| i10-index | 284 |
| Last Known Institution | Jnana Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5071800834 |
| ORCID iD | https://orcid.org/0000-0002-8123-4065 |
| Works | 1,016 |

## Researcher papers

- [Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages](https://scholariq.org/papers/revised-classification-of-histiocytoses-and-neoplasms-of-the-macrophage/)
- [Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer](https://scholariq.org/papers/phase-ii-pilot-study-of-vemurafenib-in-patients-with-metastatic-i-braf-i-mutated/)
- [Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative](https://scholariq.org/papers/personalized-medicine-in-a-phase-i-clinical-trials-program-the-md-anderson/)
- [Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses](https://scholariq.org/papers/intratumoral-injection-of-i-clostridium-novyi-i-nt-spores-induces-antitumor/)
- [Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial](https://scholariq.org/papers/vorasidenib-a-dual-inhibitor-of-mutant-idh1-2-in-recurrent-or-progressive-glioma/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

## Researcher university

- [Jnana Therapeutics (United States)](https://scholariq.org/institutions/jnana-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.